Ligand says FDA extends blood-clot drug review - Forbes
Published by Google Inc. June 20th, 2008 in Google FDA News, Regulatory AffairsLigand says FDA extends blood-clot drug review
Forbes, NY - AP 06.20.08, 4:31 PM ET Drug developer Ligand Pharmaceuticals Inc. said after the bell Friday the Food and Drug Administration will take an additional three … Ligand Partner GlaxoSmithKline Receives FDA Extended Priority … GSK Update on FDA Review of Promacta(R) (Eltrombopag) GlaxoSmithKline: FDA extends priority review period for Promacta |